122 related articles for article (PubMed ID: 3016359)
1. [Stability of high molecular weight anticancer agent SMANCS and its transfer from oil-phase to water-phase. Comparative study with neocarzinostatin].
Hirayama S; Sato F; Oda T; Maeda H
Jpn J Antibiot; 1986 Mar; 39(3):815-22. PubMed ID: 3016359
[TBL] [Abstract][Full Text] [Related]
2. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
Yamasaki K; Konno T; Miyauchi Y; Maeda H
Cancer Res; 1987 Feb; 47(3):852-5. PubMed ID: 3026619
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein].
Yamasaki K; Konno T; Miyauchi Y; Maeda H
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1224-8. PubMed ID: 3034169
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodes.
Ohtsuka N; Konno T; Miyauchi Y; Maeda H
Cancer; 1987 May; 59(9):1560-5. PubMed ID: 3030530
[TBL] [Abstract][Full Text] [Related]
5. Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma.
Abe S; Otsuki M
Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):715-26. PubMed ID: 12678722
[TBL] [Abstract][Full Text] [Related]
6. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
Maeda H
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
Kimura M; Konno T; Ohtsuka N; Mizumachi R; Oda T
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2183-8. PubMed ID: 2544148
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
Oda T; Sato F; Yamamoto H; Akagi M; Maeda H
Anticancer Res; 1989; 9(2):261-5. PubMed ID: 2526613
[TBL] [Abstract][Full Text] [Related]
9. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.
Iwai K; Maeda H; Konno T
Cancer Res; 1984 May; 44(5):2115-21. PubMed ID: 6324996
[TBL] [Abstract][Full Text] [Related]
10. Treatment of renal cell carcinoma with intra-arterial administration of SMANCS dissolved in Lipiodol.
Noda S; Konno S; Tanaka J; Yamada M; Yoshitake N
Anticancer Res; 1990; 10(3):709-15. PubMed ID: 2164351
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeted chemotherapy with lipid contrast medium and macromolecular anticancer drug (SMANCS) for renal cell carcinoma.
Kobayashi M; Imai K; Sugihara S; Maeda H; Konno T; Yamanaka H
Urology; 1991 Mar; 37(3):288-94. PubMed ID: 1848030
[TBL] [Abstract][Full Text] [Related]
12. Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
Oda T; Sato F; Maeda H
J Natl Cancer Inst; 1987 Dec; 79(6):1205-11. PubMed ID: 2961908
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.
Kimoto A; Konno T; Kawaguchi T; Miyauchi Y; Maeda H
Cancer Res; 1992 Feb; 52(4):1013-7. PubMed ID: 1531320
[TBL] [Abstract][Full Text] [Related]
14. [CT image of the liver cancer after administration of SMANCS/lipiodol].
Maki S; Konno T; Iwai K; Tashiro S; Otsuka N; Yamasaki K; Mizutani J; Miyauchi Y; Maeda H; Yokoyama I
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1603-10. PubMed ID: 3015036
[TBL] [Abstract][Full Text] [Related]
15. [SMANCS/lipiodol].
Maeda H
Gan To Kagaku Ryoho; 1994 May; 21(6):907-13. PubMed ID: 8185354
[TBL] [Abstract][Full Text] [Related]
16. Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors.
Tsuchiya K; Uchida T; Kobayashi M; Maeda H; Konno T; Yamanaka H
Urology; 2000 Apr; 55(4):495-500. PubMed ID: 10736490
[TBL] [Abstract][Full Text] [Related]
17. [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
Suzuki F; Okuno Y; Maeda Y; Maeda H
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3305-12. PubMed ID: 2961306
[TBL] [Abstract][Full Text] [Related]
18. Experience with intraarterial infusion of styrene maleic acid neocarzinostatin (SMANCS)-lipiodol in pancreatic cancer.
Yoshida H; Onda M; Tajiri T; Uchida E; Arima Y; Mamada Y; Yamamoto K; Kaneko M; Terada Y; Kumazaki T
Hepatogastroenterology; 1999; 46(28):2612-5. PubMed ID: 10522050
[TBL] [Abstract][Full Text] [Related]
19. Differential neutralizing effect of tiopronin on the toxicity of neocarzinostatin and SMANCS: a new rescue cancer chemotherapy.
Oda T; Yamamoto H; Miki T; Maeda H
Jpn J Cancer Res; 1989 Apr; 80(4):394-9. PubMed ID: 2526108
[TBL] [Abstract][Full Text] [Related]
20. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
